1. Home
  2. VSTS vs MIRM Comparison

VSTS vs MIRM Comparison

Compare VSTS & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTS
  • MIRM
  • Stock Information
  • Founded
  • VSTS 1936
  • MIRM 2018
  • Country
  • VSTS United States
  • MIRM United States
  • Employees
  • VSTS N/A
  • MIRM N/A
  • Industry
  • VSTS
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTS
  • MIRM Health Care
  • Exchange
  • VSTS Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • VSTS 2.2B
  • MIRM 2.1B
  • IPO Year
  • VSTS N/A
  • MIRM 2019
  • Fundamental
  • Price
  • VSTS $16.26
  • MIRM $47.98
  • Analyst Decision
  • VSTS Hold
  • MIRM Strong Buy
  • Analyst Count
  • VSTS 5
  • MIRM 11
  • Target Price
  • VSTS $14.08
  • MIRM $57.00
  • AVG Volume (30 Days)
  • VSTS 2.4M
  • MIRM 432.9K
  • Earning Date
  • VSTS 01-31-2025
  • MIRM 02-26-2025
  • Dividend Yield
  • VSTS 0.86%
  • MIRM N/A
  • EPS Growth
  • VSTS N/A
  • MIRM N/A
  • EPS
  • VSTS 0.16
  • MIRM N/A
  • Revenue
  • VSTS $2,805,820,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • VSTS $2.82
  • MIRM $82.63
  • Revenue Next Year
  • VSTS $2.98
  • MIRM $26.43
  • P/E Ratio
  • VSTS $102.53
  • MIRM N/A
  • Revenue Growth
  • VSTS N/A
  • MIRM 112.14
  • 52 Week Low
  • VSTS $8.92
  • MIRM $23.14
  • 52 Week High
  • VSTS $22.37
  • MIRM $48.89
  • Technical
  • Relative Strength Index (RSI)
  • VSTS 58.09
  • MIRM 68.78
  • Support Level
  • VSTS $16.07
  • MIRM $45.26
  • Resistance Level
  • VSTS $16.56
  • MIRM $47.25
  • Average True Range (ATR)
  • VSTS 0.42
  • MIRM 1.56
  • MACD
  • VSTS 0.04
  • MIRM 0.66
  • Stochastic Oscillator
  • VSTS 85.36
  • MIRM 91.60

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: